HBT Financial (NASDAQ:HBT) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.40 by 22.5 percent. This is a 8.89 percent increase over earnings of $0.45 per share from the same period last year.
Raymond James Maintains Strong Buy on Apellis Pharmaceuticals, Raises Price Target to $114
Raymond James analyst Timur Ivannikov maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Strong Buy and raises the price target from $112 to $114.
